Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Market Cap	8.16B +70.8%
Revenue (ttm)	1.19B +25.1%
Net Income	229.49M +14.0%
EPS	1.40 +14.2%
Shares Out	209.45M
PE Ratio	27.88
Forward PE	n/a
Dividend	0.26 (0.68%)
Ex-Dividend Date	Jun 3, 2026

Volume	219,200
Average Volume	264,980
Open	38.22
Previous Close	38.20
Day's Range	38.00 - 40.46
52-Week Range	20.10 - 41.40
Beta	0.06
RSI	70.81
Earnings Date	Mar 27, 2026

About HKG:1501

Shanghai INT Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers digital inflation devices; cardiac valves balloon inflation catheter; guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire; angiography catheter use...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2006
• Employees: 2,007
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1501

Financial Performance

In 2025, HKG:1501's revenue was 1.07 billion, an increase of 25.06% compared to the previous year's 851.95 million. Earnings were 206.23 million, an increase of 13.99%.

Financial numbers in CNY